CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

CREATE Medicines, Inc. (CREATE), a clinical-stage biotechnology company pioneering in vivo immune programming, announced a strategic research collaboration with Australia’s Monash University and its world-leading Monash Institute of Pharmaceutical Sciences…